2021

1. Value of PD-L1, PD-1, and CTLA-4 Expression in the Clinical Practice as Predictors of Response to Nivolumab and Ipilimumab in Monotherapy in Patients With Advanced Stage Melanoma

   The American Journal of dermatopathology, Vol. 43, Núm. 6, pp. 423-428